6236 Stock Overview
Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Neith Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$33.90 |
| 52 Week High | NT$37.80 |
| 52 Week Low | NT$17.60 |
| Beta | -0.022 |
| 1 Month Change | 3.35% |
| 3 Month Change | 2.73% |
| 1 Year Change | 62.20% |
| 3 Year Change | 276.67% |
| 5 Year Change | 133.79% |
| Change since IPO | -88.61% |
Recent News & Updates
Shareholder Returns
| 6236 | TW Semiconductor | TW Market | |
|---|---|---|---|
| 7D | 1.2% | -8.3% | -5.7% |
| 1Y | 62.2% | 39.1% | 23.8% |
Return vs Industry: 6236 exceeded the TW Semiconductor industry which returned 39.1% over the past year.
Return vs Market: 6236 exceeded the TW Market which returned 23.8% over the past year.
Price Volatility
| 6236 volatility | |
|---|---|
| 6236 Average Weekly Movement | n/a |
| Semiconductor Industry Average Movement | 5.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.5% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6236 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 6236's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Chun Wu | www.cometruebio.com |
Neith Corporation engages in the biotechnology, medical cosmetics, and preventive medicine businesses. The company offers nutritional products, including L-One, a liquid formula for maintaining eye health; EPlus, a multiple enzyme supplement; Max Care antrodia and turmeric capsules; and Max Care natto monascus capsules, as well as other nutritional products under the King One name. It also provides genetic testing services.
Neith Corporation Fundamentals Summary
| 6236 fundamental statistics | |
|---|---|
| Market cap | NT$1.41b |
| Earnings (TTM) | -NT$40.03m |
| Revenue (TTM) | NT$39.90m |
35.4x
P/S Ratio-35.3x
P/E RatioIs 6236 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6236 income statement (TTM) | |
|---|---|
| Revenue | NT$39.90m |
| Cost of Revenue | NT$21.88m |
| Gross Profit | NT$18.02m |
| Other Expenses | NT$58.05m |
| Earnings | -NT$40.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.96 |
| Gross Margin | 45.16% |
| Net Profit Margin | -100.33% |
| Debt/Equity Ratio | 0% |
How did 6236 perform over the long term?
See historical performance and comparison